FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Clark

Research Profile

Disorders

Concepts & Ideas

Anatomy

Chemicals & Drugs

Physiology

Disease Progression

Procedures

Diagnosis, Differential

Co-author Network

Publications

TOP 3
Selam Negash; Leslie M Shaw; John Q Trojanowski; David A Wolk; Sharon Xie; Christopher M Clark; Christos Davatzikos; Steven E Arnold
Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
David A Wolk; Zheng Zhang; Sanaa Boudhar; Christopher M Clark; Michael J Pontecorvo; Steven E Arnold
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
William T Hu; Howard I Hurtig; Jason Karlawish; Max Kuhn; Virginia M-Y Lee; Leo McCluskey; John C Morris; Richard Perrin; Eve Pickering; Leslie M Shaw; Andrew Siderowf; Holly Soares; Frank Swenson; John Q Trojanowski; Vivianna M Van Deerlin; Chengjie Xiong; Steven E Arnold; Yu Chen; Alice Chen-Plotkin; Christopher M Clark; Rebecca Craig-Schapiro; Lauren B Elman; Anne M Fagan; Murray Grossman; David M Holtzman
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Clark (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Selam Negash; Leslie M Shaw; John Q Trojanowski; David A Wolk; Sharon Xie; Christopher M Clark; Christos Davatzikos; Steven E Arnold
Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2013;9(3):e89-95.
2012: David A Wolk; Zheng Zhang; Sanaa Boudhar; Christopher M Clark; Michael J Pontecorvo; Steven E Arnold
Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
Journal of neurology, neurosurgery, and psychiatry 2012;83(9):923-6.
2012: William T Hu; Howard I Hurtig; Jason Karlawish; Max Kuhn; Virginia M-Y Lee; Leo McCluskey; John C Morris; Richard Perrin; Eve Pickering; Leslie M Shaw; Andrew Siderowf; Holly Soares; Frank Swenson; John Q Trojanowski; Vivianna M Van Deerlin; Chengjie Xiong; Steven E Arnold; Yu Chen; Alice Chen-Plotkin; Christopher M Clark; Rebecca Craig-Schapiro; Lauren B Elman; Anne M Fagan; Murray Grossman; David M Holtzman
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease.
Neurology 2012;79(9):897-905.
2012: Li-San Wang; Young Baek; Shu-Kai Chang; Malgorzata Knapik-Czajka; Virginia M-Y Lee; Susan Leight; Yuk Yee Leung; Leslie M Shaw; John Q Trojanowski; Christopher M Clark
Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2012;31(2):439-45.
2012: Sunil Patel; Leslie M Shaw; John Q Trojanowski; Sharon X Xie; Steven E Arnold; Christopher M Clark; M Sean Grady; Eric M Jackson; Anica Law; Edward B Lee; Roy H Hamilton
Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus.
Fluids and barriers of the CNS 2012;9(1):7.
2012: Daniel Weintraub; David A Wolk; Sharon X Xie; Christopher M Clark; Christos Davatzikos; Nicole Dietz; Jimit Doshi; John E Duda; Andrew Siderowf
Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
Brain : a journal of neurology 2012;135(Pt 1):170-80.
2011: Alice S Chen-Plotkin; William T Hu; Andrew Siderowf; Daniel Weintraub; Rachel Goldmann Gross; Howard I Hurtig; Sharon X Xie; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Vivianna M Van Deerlin; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.
Annals of neurology 2011;69(4):655-63.
2011: Mohammad Haris; Anup Singh; Kejia Cai; Erin McArdle; Matthew Fenty; Christos Davatzikos; John Q Trojanowski; Elias Melhem; Christopher M Clark; Arijitt Borthakur
T(1ρ) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2011;21(2):e86-90.
2011: Lynn Bekris; N M Galloway; S Millard; David J Lockhart; Ge Li; Douglas Galasko; Martin R Farlow; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; Gerard D Schellenberg; James B Leverenz; Peter Seubert; Debby W Tsuang; Elaine Peskind; Chang-En Yu
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
Neurobiology of aging 2011;32(3):556.e13-23.
2011: Kyle B Womack; Ramon Diaz-Arrastia; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; Christopher M Clark; Charles DeCarli; William J Jagust; James B Leverenz; Elaine Peskind; Raymond Scott Turner; Edward Y Zamrini; Judith L Heidebrink; James R Burke; Steven T DeKosky; Martin R Farlow; Matthew J Gabel; Roger Higdon; Claudia H Kawas; Robert A Koeppe; Anne M Lipton; Norman L Foster
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
Archives of neurology 2011;68(3):329-37.
2011: Mohammad Haris; Anup Singh; Kejia Cai; Christos Davatzikos; John Q Trojanowski; Elias Melhem; Christopher M Clark; Arijitt Borthakur
T1rho (T1ρ) MR imaging in Alzheimer's disease and Parkinson's disease with and without dementia.
Journal of neurology 2011;258(3):380-5.
2011: Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine Peskind; Ge Li; Douglas Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.
PloS one 2011;6(1):e16032.
2010: W T Hu; A Chen-Plotkin; Murray Grossman; Steven E Arnold; Christopher M Clark; L M Shaw; Leo McCluskey; Lauren B Elman; Howard I Hurtig; Andrew Siderowf; V M-Y Lee; H Soares; John Q Trojanowski
Novel CSF biomarkers for frontotemporal lobar degenerations.
Neurology 2010;75(23):2079-86.
2010: Matthew J Gabel; Norman L Foster; Judith L Heidebrink; Roger Higdon; Howard J Aizenstein; Steven E Arnold; Nancy R Barbas; Bradley F Boeve; James R Burke; Christopher M Clark; Steven T DeKosky; Martin R Farlow; William J Jagust; Claudia H Kawas; Robert A Koeppe; James B Leverenz; Anne M Lipton; Elaine Peskind; Raymond Scott Turner; Kyle B Womack; Edward Y Zamrini
Validation of consensus panel diagnosis in dementia.
Archives of neurology 2010;67(12):1506-12.
2010: Roy Hamilton; Sunil Patel; Edward B Lee; Eric M Jackson; Joanna Lopinto; Steven E Arnold; Christopher M Clark; Anuj Basil; Leslie M Shaw; Sharon X Xie; M Sean Grady; John Q Trojanowski
Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.
Annals of neurology 2010;68(4):535-40.
2010: William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.
Acta neuropathologica 2010;120(3):385-99.
2010: Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(24):2209-16.
2010: William T Hu; Alice Chen-Plotkin; Steven E Arnold; Murray Grossman; Christopher M Clark; Leslie M Shaw; Eve Pickering; Max Kuhn; Yu Chen; Leo McCluskey; Lauren Elman; Jason Karlawish; Howard I Hurtig; Andrew Siderowf; Virginia M-Y Lee; Holly Soares; John Q Trojanowski
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.
Acta neuropathologica 2010;119(6):669-78.
2010: John Q Trojanowski; Hugo Vandeerstichele; Magdalena Korecka; Christopher M Clark; Paul S Aisen; Ronald C. Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Z Potter; Michael Weiner; Clifford R Jack; William J Jagust; Arthur W Toga; Virginia M-Y Lee; Leslie M Shaw
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2010;6(3):230-8.
2009: J Nicholas Lukens; Vivianna M Van Deerlin; Christopher M Clark; Sharon X Xie; F Brad Johnson
Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(6):463-9.
2009: Sharon X Xie; Douglas C Ewbank; Jesse Chittams; Jason H T Karlawish; Steven E Arnold; Christopher M Clark
Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale.
Alzheimer disease and associated disorders 2009;23(3):268-74.
2009: Mohammad Haris; Erin McArdle; Matthew Fenty; Anup Singh; Christos Davatzikos; John Q Trojanowski; Elias Melhem; Christopher M Clark; Arijitt Borthakur
Early marker for Alzheimer's disease: hippocampus T1rho (T(1rho)) estimation.
Journal of magnetic resonance imaging : JMRI 2009;29(5):1008-12.
2009: Leslie M Shaw; hugo vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C. Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.
Annals of neurology 2009;65(4):403-13.
2008: Arijitt Borthakur; Matthew Sochor; Christos Davatzikos; John Q Trojanowski; Christopher M Clark
T1rho MRI of Alzheimer's disease.
NeuroImage 2008;41(4):1199-205.
2008: Christos Davatzikos; S M Resnick; X Wu; P Parmpi; Christopher M Clark
Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.
NeuroImage 2008;41(4):1220-7.
2008: Lionel M Igaz; Linda K Kwong; Yan Xu; Adam C Truax; Kunihiro Uryu; Manuela Neumann; Christopher M Clark; Lauren B Elman; Bruce L Miller; Murray Grossman; Leo McCluskey; John Q Trojanowski; Virginia M-Y Lee
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
The American journal of pathology 2008;173(1):182-94.
2008: Kunihiro Uryu; Hanae Nakashima-Yasuda; Mark S Forman; Linda K Kwong; Christopher M Clark; Murray Grossman; Bruce L Miller; Hans A Kretzschmar; Virginia M-Y Lee; John Q Trojanowski; Manuela Neumann
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
Journal of neuropathology and experimental neurology 2008;67(6):555-64.
2008: Alice S Chen-Plotkin; Felix Geser; Joshua B Plotkin; Christopher M Clark; Linda K Kwong; Wuxing Yuan; Murray Grossman; Vivianna M Van Deerlin; John Q Trojanowski; Virginia M-Y Lee
Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.
Human molecular genetics 2008;17(10):1349-62.
2008: H Bian; J C Van Swieten; Susan Leight; Lauren Massimo; E Wood; M Forman; Peachie Moore; I de Koning; Christopher M Clark; S Rosso; John Q Trojanowski; Virginia M-Y Lee; Murray Grossman
CSF biomarkers in frontotemporal lobar degeneration with known pathology.
Neurology 2008;70(19 Pt 2):1827-35.
2008: Yong Fan; Nematollah Batmanghelich; Christopher M Clark; Christos Davatzikos
Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline.
NeuroImage 2008;39(4):1731-43.
2008: A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; Howard I Hurtig; Christopher M Clark; Bruce L Miller; Virginia M-Y Lee; John Q Trojanowski; Murray Grossman; Vivianna M Van Deerlin
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.
Neurology 2008;70(7):521-7.
2008: Sharon X Xie; Mark S Forman; Jennifer Farmer; Peachie Moore; Y Wang; X Wang; Christopher M Clark; H Branch Coslett; Anjan Chatterjee; Steven E Arnold; H Rosen; Jason H T Karlawish; Vivianna M Van Deerlin; Virginia M-Y Lee; John Q Trojanowski; Murray Grossman
Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration.
Journal of neurology, neurosurgery, and psychiatry 2008;79(2):126-9.
2008: Christopher M Clark; Christos Davatzikos; A Borthakur; A Newberg; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Biomarkers for early detection of Alzheimer pathology.
Neuro-Signals 2008;16(1):11-8.
2007: Murray Grossman; David J Libon; Mark S Forman; Lauren Massimo; Elisabeth Wood; Peachie Moore; Chivon Anderson; Jennifer Farmer; Anjan Chatterjee; Christopher M Clark; H Branch Coslett; Howard I Hurtig; Virginia M-Y Lee; John Q Trojanowski
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia.
Archives of neurology 2007;64(11):1601-9.
2007: Murray Grossman; Elisabeth M Wood; Peachie Moore; Manuela Neumann; Linda K Kwong; Mark S Forman; Christopher M Clark; Leo McCluskey; Bruce L Miller; Virginia M-Y Lee; John Q Trojanowski
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
Archives of neurology 2007;64(10):1449-54.
2007: Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles DeCarli; Raymond Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.
Brain : a journal of neurology 2007;130(Pt 10):2616-35.
2007: Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard I Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randall L Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey A Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.
Acta neuropathologica 2007;114(3):221-9.
2007: Vivianna M Van Deerlin; Elisabeth McCarty Wood; Peachie Moore; Wuxing Yuan; Mark S Forman; Christopher M Clark; Manuela Neumann; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee; Murray Grossman
Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations.
Archives of neurology 2007;64(8):1148-53.
2007: R Murray; Manuela Neumann; Mark S Forman; Jennifer Farmer; Lauren Massimo; A Rice; Bruce L Miller; Julene K Johnson; Christopher M Clark; Howard I Hurtig; Maria Luisa Gorno-Tempini; Virginia M-Y Lee; John Q Trojanowski; Murray Grossman
Cognitive and motor assessment in autopsy-proven corticobasal degeneration.
Neurology 2007;68(16):1274-83.
2007: Leslie M Shaw; Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
Nature reviews. Drug discovery 2007;6(4):295-303.
2007: Manuela Neumann; Linda K Kwong; Adam C Truax; Ben Vanmassenhove; Hans A Kretzschmar; Vivianna M Van Deerlin; Christopher M Clark; Murray Grossman; Bruce L Miller; John Q Trojanowski; Virginia M-Y Lee
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
Journal of neuropathology and experimental neurology 2007;66(3):177-83.
2006: Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo McCluskey; Bruce L Miller; Eliezer Masliah; Ian R A Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Science (New York, N.Y.) 2006;314(5796):130-3.
2006: Christopher M Clark; Domenico Pratico'; Lesley M Shaw; Susan Leight; Sharon X Xie; Amy Gu; Virginia M-Y Lee; John Q Trojanowski
Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2006;2(4):287-93.
2006: Elaine Peskind; Ge Li; Jane B Shofer; Joseph F Quinn; Jeffrey A Kaye; Christopher M Clark; Martin R Farlow; Charles DeCarli; Murray A Raskind; Gerard D Schellenberg; Virginia M-Y Lee; Douglas Galasko
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.
Archives of neurology 2006;63(7):936-9.
2006: Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H T Karlawish; Howard J Rosen; Vivianna M Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Frontotemporal dementia: clinicopathological correlations.
Annals of neurology 2006;59(6):952-62.
2006: Andrew B Newberg; Nancy Wintering; Karl Plössl; John Hochold; Michael G Stabin; Marianne Watson; Daniel M Skovronsky; Christopher M Clark; Mei-Ping Kung; Hank F Kung
Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(5):748-54.
2005: Elaine Peskind; Robert G Riekse; Joseph F Quinn; Jeffrey A Kaye; Christopher M Clark; Martin R Farlow; Charles DeCarli; Charles Chabal; Darcy Vavrek; Murray A Raskind; Douglas Galasko
Safety and acceptability of the research lumbar puncture.
Alzheimer disease and associated disorders 2005;19(4):220-5.
2005: Yuemang Yao; Christopher M Clark; John Q Trojanowski; Virginia M-Y Lee; Domenico Pratico'
Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment.
Annals of neurology 2005;58(4):623-6.
2005: Christopher M Clark; Charles DeCarli; Dan Mungas; Helena I Chui; Roger Higdon; Jessica Nuñez; Henrique Fernandez; Mirna Negrón; Jennifer Manly; Steven H Ferris; Angelica Perez; Migdalia Torres; Douglas C Ewbank; Guila Glosser; Gerald van Belle
Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals.
Archives of neurology 2005;62(5):774-8.
2005: Murray Grossman; Jennifer Farmer; Susan Leight; Melissa Work; Peachie Moore; Vivianna M Van Deerlin; Domenico Pratico'; Christopher M Clark; H Branch Coslett; Anjan Chatterjee; James Gee; John Q Trojanowski; Virginia M-Y Lee
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.
Annals of neurology 2005;57(5):721-9.
2004: Salina J van Rhijn; Guila Glosser; Jeroen J de Vries; Christopher M Clark; Andrew B Newberg; Abass Alavi
Visual processing impairments and decrements in regional brain activity in Alzheimer's disease.
Journal of clinical and experimental neuropsychology 2004;26(1):11-23.
2004: Roger Higdon; Norman L Foster; Robert A Koeppe; Charles DeCarli; William J Jagust; Christopher M Clark; Nancy R Barbas; Steven E Arnold; Raymond Scott Turner; Judith L Heidebrink; Satoshi Minoshima
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging.
Statistics in medicine 2004;23(2):315-26.
2003: Christopher M Clark; Sharon Xie; Jesse Chittams; Douglas C Ewbank; Elaine Peskind; Douglas Galasko; John C Morris; Daniel W McKeel; Martin R Farlow; Sharon L Weitlauf; Joseph F Quinn; Jeffrey A Kaye; David S. Knopman; Hiroyuki Arai; Rachelle S Doody; Charles DeCarli; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
Archives of neurology 2003;60(12):1696-702.
2003: Jason H T Karlawish; David Casarett; Bryan D James; Thomas TenHave; Christopher M Clark; David A Asch
Why would caregivers not want to treat their relative's Alzheimer's disease?
Journal of the American Geriatrics Society 2003;51(10):1391-7.
2003: Yuemang Yao; Victoria Zhukareva; Syuan Sung; Christopher M Clark; Joshua Rokach; Virginia M-Y Lee; John Q Trojanowski; Domenico Pratico'
Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia.
Neurology 2003;61(4):475-8.
2003: Victoria Zhukareva; Sonali Sundarraj; D M A Mann; Magnus Sjogren; Kaj Blenow; Christopher M Clark; Daniel W McKeel; Alison Goate; Carol F Lippa; Jean-Paul Vonsattel; John H Growdon; John Q Trojanowski; Virginia M-Y Lee
Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study.
Acta neuropathologica 2003;105(5):469-76.
2003: Jason H T Karlawish; Christopher M Clark
Diagnostic evaluation of elderly patients with mild memory problems.
Annals of internal medicine 2003;138(5):411-9.
2003: Christopher M Clark; Jason H T Karlawish
Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies.
Annals of internal medicine 2003;138(5):400-10.
2003: Valerie T Cotter; Christopher M Clark; Jason H T Karlawish
Cognitive function assessment in individuals at risk for Alzheimer's disease.
Journal of the American Academy of Nurse Practitioners 2003;15(2):79-86.
2002: Jason H T Karlawish; Christopher M Clark
Addressing the challenges of transforming laboratory advances into Alzheimer's Disease treatments.
Neurobiology of aging 2002;23(6):1043-9.
2002: Guila Glosser; Jennifer Gallo; Nanci Duda; Jeroen J de Vries; Christopher M Clark; Murray Grossman
Visual perceptual functions predict instrumental activities of daily living in patients with dementia.
Neuropsychiatry, neuropsychology, and behavioral neurology 2002;15(3):198-206.
2002: Domenico Pratico'; Christopher M Clark; Feyan Liun; Joshua Rokach; Virginia M-Y Lee; John Q Trojanowski
Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.
Archives of neurology 2002;59(6):972-6.
2002: Guila Glosser; Jennifer L Gallo; Christopher M Clark; Murray Grossman
Memory encoding and retrieval in frontotemporal dementia and Alzheimer's disease.
Neuropsychology 2002;16(2):190-6.
2002: Jason H T Karlawish; David Casarett; Kathleen J Propert; Bryan D James; Christopher M Clark
Relationship between Alzheimer's disease severity and patient participation in decisions about their medical care.
Journal of geriatric psychiatry and neurology 2002;15(2):68-72.
2002: Guila Glosser; Krista M Baker; Jeroen J de Vries; Abass Alavi; Murray Grossman; Christopher M Clark
Disturbed visual processing contributes to impaired reading in Alzheimer's disease.
Neuropsychologia 2002;40(7):902-9.
2001: Jason H T Karlawish; David Casarett; JL Klocinski; Christopher M Clark
The relationship between caregivers' global ratings of Alzheimer's disease patients' quality of life, disease severity, and the caregiving experience.
Journal of the American Geriatrics Society 2001;49(8):1066-70.
2001: Victoria Zhukareva; Vanessa Vogelsberg-Ragaglia; Vivianna M Van Deerlin; J Bruce; T Shuck; Murray Grossman; Christopher M Clark; Steven E Arnold; Eliezer Masliah; Douglas Galasko; John Q Trojanowski; Virginia M-Y Lee
Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia.
Annals of neurology 2001;49(2):165-75.
2000: Steven E Arnold; Li-Ying Han; Christopher M Clark; Murray Grossman; John Q Trojanowski
Quantitative neurohistological features of frontotemporal degeneration.
Neurobiology of aging 2000;21(6):913-9.
2000: Domenico Pratico'; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski; Joshua Rokach; garret fitzgerald
Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
Annals of neurology 2000;48(5):809-12.
2000: Jason H T Karlawish; JL Klocinski; J Merz; Christopher M Clark; David A Asch
Caregivers' preferences for the treatment of patients with Alzheimer's disease.
Neurology 2000;55(7):1008-14.
2000: Howard I Hurtig; John Q Trojanowski; James E Galvin; Douglas C Ewbank; M Luise Schmidt; Virginia M-Y Lee; Christopher M Clark; Guila Glosser; Matthew B Stern; SM Gollomp; Steven E Arnold
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.
Neurology 2000;54(10):1916-21.
1999: Christopher M Clark; Elizabeth A Sheppard; Gerda fillenbaum; Douglas Galasko; John C Morris; Elizabeth Koss; Richard C Mohs; Albert Heyman
Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease.
Archives of neurology 1999;56(7):857-62.
1997: John Q Trojanowski; Christopher M Clark; M Luise Schmidt; Steven E Arnold; Virginia M-Y Lee
Strategies for improving the postmortem neuropathological diagnosis of Alzheimer's disease.
Neurobiology of aging 1997;18(4 Suppl):S75-9.
1997: Christopher M Clark; Douglas C Ewbank; A Lerner; Rachelle S Doody; Victor W. Henderson; M Panisset; John C Morris; Gerda fillenbaum; Albert Heyman
The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
Neurology 1997;49(1):70-5.